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        Introduction 
  Cytoplasmic tyrosine kinases of the Src family (Src family pro-
tein tyrosine kinases [SFK]) play important roles in signal 
transduction induced by a large number of extracellular stimuli 
including growth factors, integrins, and cytokines (  Martin, 2001  ). 
For example, they control cellular responses induced by PDGF 
such as mitogenesis, survival, and cytoskeleton rearrangement. 
In contrast to several mitogens, PDGF-induced SFK activation 
does not have an impact on the Ras  –  MAPK pathway but, rather, 
controls   c-myc   expression that is needed for cell cycle progres-
sion (  Bromann et al., 2004  ). Several Src substrates promoting 
mitogenic signaling have been characterized, including Shc, 
Stat3, Vav2, and Abl (  Bromann et al., 2004  ). Rac has been fur-
ther identifi  ed as an important element of Abl signaling, and we 
have shown that Src-induced   c-myc   expression and cell cycle 
progression need Rac/Jun N-terminal kinase and Rac  –  NADPH 
oxidase signaling pathways (  Boureux et al., 2005  ). Intriguingly, 
requirement of SFK is also dependent on functional p53 (  Broome 
and Courtneidge, 2000  ;   Furstoss et al., 2002  ). Although not 
completely understood, data from   Niu et al. (2005)   suggest that 
Stat3 mediates p53 down-regulation, an event which is required 
for late G1 progression. Nevertheless, additional regulatory 
mechanisms might be envisaged. 
  How Src induces signaling specifi  city is not clearly estab-
lished. Although phosphorylation of appropriate substrates 
may be part of the mechanism, spatial regulation could also 
be implicated. Indeed, SFK localization at focal adhesions is 
crucial for cell adhesion and migration (  Frame, 2004  ), and ac-
cumulation in plasma membrane lipid rafts is apparently important 
for T and B cell receptor activation (  Janes et al., 1999  ). Lipid 
rafts are somewhat controversial structures, defi  ned as micro-
domains enriched in cholesterol and sphingolipids which con-
centrate and regulate signaling proteins at the plasma membrane 
(  Horejsi, 2005  ). In nonlymphoid cells, this function may be 
partially   ensured by caveolae. These membrane invaginations 
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  kinases [SFK]). Cholesterol-enriched membrane domains, 
such as caveolae, regulate association of SFK with the 
platelet-derived growth factor receptor (PDGFR), which is 
needed for kinase activation and mitogenic signaling. 
PAG, a ubiquitously expressed member of the transmem-
brane adaptor protein family, is known to negatively 
  regulate SFK signaling though binding to Csk. We report 
that PAG modulates PDGFR levels in caveolae and SFK 
mitogenic signaling through a Csk-independent mecha-
nism. Regulation of SFK mitogenic activity by PAG re-
quires the ﬁ  rst N-terminal 97 aa (PAG-N), which include 
the extracellular and transmembrane domains, palmi-
toylation sites, and a short cytoplasmic sequence. We also 
show that PAG-N increases ganglioside GM1 levels at the 
cell surface and, thus, displaces PDGFR from caveolae, a 
process that requires the ganglioside-speciﬁ  c  sialidase 
Neu-3. In conclusion, PAG regulates PDGFR membrane 
partitioning and SFK mitogenic signaling by modulating 
GM1 levels within caveolae independently from Csk.
  The Csk-binding protein PAG regulates 
PDGF-induced Src mitogenic signaling via GM1 
    Laurence     Veracini  ,   
1       Val  é  rie     Simon  ,   
1       V  é  ronique     Richard  ,   
2       Burkhart     Schraven  ,   
3       Vaclav     Horejsi  ,   
4       Serge     Roche  ,   
1     
and   Christine     Benistant     
1     
   
1  Centre de Recherche en Biochimie Macromol  é  culare, Centre National de la Recherche Scientiﬁ  que UMR5237, Universities of Montpellier I and II, 34293 Montpellier, France 
   
2  Electronic microscopy facility, University of Montpellier II, Montpellier, France 
   
3  Otto-von-Guericke-University, 39120 Magdeburg, Germany 
   
4  Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Prague, Czech Republic       
© 2008 Veracini et al.  This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the ﬁ  rst six months after the publica-
tion date (see http://www.jcb.org/misc/terms.shtml). After six months it is available under a 
Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, 
as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).JCB • VOLUME 182 • NUMBER 3 • 2008  604
plasma membrane, whereas Csk is strictly cytosolic. Thus, in vivo 
activity requires membrane-associated Csk binders that allow 
its recruitment to subcellular compartments where SFK reside. 
For example, paxillin recruits Csk to the focal adhesions that 
may regulate SFK adhesive and migratory functions (  Baumeister 
et al., 2005  ), whereas Dok-1 induces Csk translocation to the 
plasma membrane for mitogenic regulation (  Zhao et al., 2006  ). 
This regulation is governed by a Csk-SH2 pTyr-dependent 
mechanism, and phosphorylation of Csk-binding proteins is 
triggered by SFK, which defi  nes a negative-feedback regula-
tory loop. 
  Recently, a novel group of signaling proteins has emerged 
that may also be involved in SFK signaling and its regulation 
during immunoreceptor stimulation. This family, called TRAPs 
(transmembrane adaptor proteins), currently comprises seven 
members, the founder being LAT (the linker of activation of 
T cells;   Horejsi et al., 2004  ). They all contain a short extracellu-
lar single transmembrane and a long intracellular domain with 
tyrosine motifs that potentially interact with SH2 domains of 
other signaling proteins. For example, LAT comprises four Tyr 
that, when phosphorylated by ZAP70 (a downstream effector of 
the SFK Lck and Fyn), create binding sites for PLC     and Grb2, 
which are both required for effi  cient T cell activation. Another 
member of this family, PAG (phosphoprotein associated with 
glycosphingolipid-enriched microdomains;   Brdicka et al., 2000  ), 
also called Cbp (Csk-binding protein;   Kawabuchi et al., 2000  ), 
is ubiquitously expressed, unlike other members of the family 
whose expression is mostly restricted to hematopoietic tissues. 
PAG contains 10 Tyr residues in the cytoplasmic domain, 9 
of which are SFK phosphorylation sites, 2 poly-Pro motifs for 
  interaction with SH3-containing proteins, and 2 potential pal-
mitoylation sites implicated in lipid rafts localization (  Horejsi 
et al., 2004  ). It may allow Csk recruitment in these structures 
through interaction of Csk-SH2 with pTyr317. Thus, PAG may 
defi  ne an additional negative regulatory loop toward SFK in mem-
brane domains such as caveolae (  Shima et al., 2003  ). In this 
  paper, we have addressed the role of PAG in the regulation of 
SFK mitogenic signaling. We show that this adaptor, indepen-
dently of binding to Csk, regulates PDGFR partitioning at the 
plasma membrane through the ganglioside GM1. 
  Results 
  PAG negatively regulates Src mitogenic 
signaling 
 We  fi  rst addressed the role of Csk in the PDGF-induced Src 
  mitogenic signal transduction pathway. To this end, we trans-
fected NIH 3T3 cells with a Csk-expressing construct. After se-
rum starvation, we stimulated the transfected cells with PDGF 
for cell cycle reentry and monitored de novo DNA synthesis 
by BrdU incorporation into the nuclei. PDGF stimulation in-
duced a 50% BrdU incorporation in control cells, which was 
  inhibited by Csk overexpression (  Fig. 1 A  ). 
[ID]FIG1[/ID]  DNA synthesis was 
restored by coexpression of the transcription factor Myc or 
the active RacV12 mutant of the Rho family of small GTPases, 
two elements of the Src pathway (  Bromann et al., 2004  ;   Boureux 
et al., 2005  ). In contrast, the active RasL61 mutant could not 
are composed of cholesterol, sphingolipids, structural proteins 
of the caveolin family, and signaling molecules. They play cru-
cial roles in signal transduction induced by growth factors ( Pike, 
2005 ).  In  fi  broblasts, they are highly abundant, regulate the 
  localization of PDGF receptors (PDGFR), and contain probably 
  >  25% of the SFK present in these cells (  Veracini et al., 2006  ). 
We have recently reported that these domains regulate SFK 
  mitogenic signaling through SFK  –  PDGFR complex formation. 
In contrast, caveolae do not control PDGF-induced SFK signal-
ing leading to F-actin assembly for dorsal ruffl  es formation 
  (  Veracini et al., 2006  ). Therefore, proteins that regulate tyrosine 
kinases in such membrane domains may play important roles in 
signaling specifi  city. 
  Src activity is subjected to a strict control based on intra-
molecular interactions of its SH2 domain with pTyr527 (phos-
phorylated Tyr527; referred to the avian Src) and of the SH3 
domain with a linker domain between the SH2 and the catalytic 
core that keep the kinase in a closed and inactive conformation 
(  Boggon and Eck, 2004  ). Phosphorylation of Tyr527 at the 
C terminus by the cytoplasmic tyrosine kinase Csk is crucial for 
SFK inactivation. Indeed,   Csk   inactivation in mice causes aber-
rant SFK activity and lethality during embryogenesis (  Imamoto 
and Soriano, 1993  ;   Nada et al., 1993  ). However, how Csk phos-
phorylates SFK in vivo is only partially understood. Although 
Src is a very good substrate in vitro, it does not interact effi  -
ciently with Csk in vivo because of the fact that Src is at the 
  Figure 1.       PAG inhibits PDGF-induced Src mitogenic signaling.   (A) Csk 
overexpression inhibits PDGF-induced Src mitogenic signaling. Quiescent 
NIH 3T3 seeded on coverslips and transfected, or not, with the indicated 
constructs were stimulated, or not, with 25 ng/ml PDGF in the presence 
of BrdU for 18 h. (B) PAG inhibits PDGF-induced Src mitogenic signaling. 
Quiescent NIH 3T3 seeded onto coverslips and transfected, or not, with 
the indicated constructs were treated as in A. (C) PAG does not inhibit 
mitogenesis in p53-deﬁ  cient cells. p53 
+/+   and p53 
    /      MEF transfected, 
or not, with a PAG-encoding construct were stimulated, or not, with PDGF 
in the presence of BrdU. (D) PAG does not affect SrcY527F-driven DNA 
synthesis. Quiescent NIH 3T3 cells transfected with the indicated con-
structs were incubated with BrdU for 18 h. Cells were then ﬁ  xed and 
processed for immunoﬂ  uorescence. The percentage of transfected cells 
that incorporated BrdU was calculated as described in Material and 
methods. Results are expressed as the mean   ±   SD of three to ﬁ  ve in-
dependent experiments.     605 SRC REGULATION BY PAG/CBP   • Veracini et al. 
expressed the adenovirus E1B (early 1B) 55K protein, which 
inhibits p53 transactivation (  Yew and Berk, 1992  ). These fi  nd-
ings are consistent with the notion that PAG might inhibit the 
Src mitogenic pathway. Interestingly, PAG did not affect the 
  capacity of oncogenic SrcY527F per se to induce DNA synthe-
sis (  Fig. 1 D  ), indicating that it may regulate signaling upstream 
of SFK, probably via a PDGF-induced SFK activation. 
  PAG mitogenic inhibition is independent 
of its interaction with Csk 
  We next asked whether PAG function was mediated by its associ-
ation with Csk. Surprisingly, we found that the PAG Y317F, a 
mutant which did not interact with Csk (  Brdicka et al., 2000  ; 
  Kawabuchi et al., 2000  ), could still inhibit mitogenesis (  Fig. 2 B  , 
left). 
[ID]FIG2[/ID]  To confi  rm this observation, we coexpressed PAG with an 
inactive form of Csk, Csk-K 
     . By associating with PAG, Csk-K 
     
was expected to prevent recruitment of endogenous Csk to mem-
brane domains and, therefore, to overcome PAG inhibitory effect. 
As this was not the case, we concluded that the PAG antimito-
genic effect is independent of its interaction with Csk. PAG con-
tains nine additional Tyr residues that, when phosphorylated, 
create binding sites for other SH2-containing signaling proteins, 
including RasGAP and the adaptor Sam68 (  Smida et al., 2007  ). 
Hence, we investigated whether one of these Tyr residues played 
a role in PAG antimitogenic effect. However, we found that all 
mutants in which a single Tyr residue was replaced by Phe were 
still inhibitory (unpublished data). We also tested the activity of 
overcome the G1 block induced by Csk, confi  rming the Ras-
  independent nature of the Src pathway (  Bromann et al., 2004  ). 
We concluded that Csk can regulate the PDGF-induced Src mito-
genic function. 
  Our previous study suggested that Src mitogenic signaling 
was initiated in caveolae (  Veracini et al., 2006  ). To confi  rm this 
data, we analyzed mitogenesis in cells with reduced level of ca-
veolin. Although caveolin-1 knockdown promoted DNA syn-
thesis by itself in 25% of NIH 3T3 cells, it signifi  cantly reduced 
PDGF mitogenic response in comparison to control cells, confi  rm-
ing the role of caveolin in this signaling pathway (Fig. S1, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200705102/DC1). 
The residual mitogenic response could be attributed to the 
moderate effi  cacy of our siRNA to reduce plasma membrane 
caveolin-1 levels in cells cultured at high density (  Galbiati et al., 
1998  ) as required for effi  cient induction of quiescence. Never-
theless, we do not exclude the involvement of additional mem-
brane domains in this cellular response. We were next interested 
in the adaptors that target Csk to these domains, particularly 
PAG. PAG overexpression strongly inhibited DNA synthesis in-
duced by PDGF (  Fig. 1 B  ). As for Csk, active RacV12 and Myc 
rescued the PDGFR signaling that was blocked by PAG. Myc 
effect was specifi  c as it was not observed by expressing Fos. 
Moreover, although PAG inhibited the mitogenic response in-
duced by PDGF in p53 
+/+   mouse embryonic fi  broblasts (MEF), 
this inhibitory effect was not observed in p53 
   /     MEF (  Fig. 1 C  ). 
A comparable result was described in NIH 3T3 cells that co-
  Figure 2.       PAG mitogenic inhibition is indepen-
dent of Csk but requires PAG palmitoylation 
sites.   (A) Schematic of the PAG constructs 
used. The extracellular (extra), transmembrane 
(TM), and cytoplasmic domains are indicated 
as well as the Csk (Y317) binding site and the 
GFP fused to PAG sequences. (B) PAG mito-
genic inhibition does not require binding to 
Csk. Quiescent NIH 3T3 cells were transfected 
with the indicated constructs and stimulated, 
or not, with PDGF in the presence of BrdU. 
(C, left) Comparison of the levels of PAG and 
PAGY317F. (C, right) PAG-N does not bind to 
Csk unlike PAG-C. Protein levels were assessed 
by Western blotting with the indicated anti-
bodies from whole cell lysates (WCL) of HEK 
293 cells expressing the shown constructs. Csk  – 
PAG complex formation was assessed by co-
immunoprecipitation with an anti-Csk antibody. 
Molecular masses are indicated in kilodaltons. 
(D) Schematic of the PAG-N constructs used. 
Palmitoylation sites are indicated. (E) Levels of 
PAG-N and PAG-NCC/AA in whole cell   lysates 
(top) and in CEF (bottom). HEK 293 cells trans-
fected with the indicated constructs were lysed 
with Triton X-100 and homogenized with a 
Dounce, followed by sucrose gradient fraction-
ation. Fractions were then directly analyzed 
by Western blotting with anti-GFP and anti-
caveolin antibodies, as indicated. The respec-
tive proteins as well as the fractions  ’   numbers 
are shown. Molecular masses are indicated 
in kilodaltons. (F) PAG-N mitogenic inhibition 
requires the palmitoylation sites. Quiescent NIH 
3T3 cells transfected with the indicated con-
structs were stimulated, or not, with PDGF in the presence of BrdU. Cells were then ﬁ  xed and processed for immunoﬂ  uorescence. The percentage of trans-
fected (or infected) cells that incorporated BrdU was calculated as described in Material and methods. Results are expressed as the mean   ±   SD of three to 
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A Triton X-100 cell lysate was fractionated through a sucrose 
gradient and CEF were isolated in the light fractions (2  –  4) as 
shown by the bulk of caveolin (  Veracini et al., 2006  ). As shown 
in   Fig. 2 E  , PAG-N was localized in CEF. Mutation of the lipid 
acylation sites Cys39 and Cys42 into Ala (PAG-N CC/AA) was 
sufficient to abrogate this localization. Interestingly, these 
  mutations also impaired the capacity of PAG-N to inhibit mito-
genesis (  Fig. 2 F  ), suggesting that targeting to caveolae and/or 
other membrane domains is required for PAG-N function. We then 
asked whether PAG-N could also regulate growth factor sig-
naling outside membrane microdomains. First, we examined 
the effect of PAG-N on PDGF-induced dorsal ruffl  e formation, 
which is known to be independent of caveolae (  Veracini et al., 
2006  ). We observed that 30% of control NIH 3T3 cells exhib-
ited at least one dorsal ruffl  e 5 min after PDGF stimulation 
(  Fig. 3 A  ) and that this response was not affected by over-
expression of PAG-N. We then analyzed the mitogenic response 
induced by EGF in NIH 3T3 cells. Although the dominant-neg-
ative Cav-3DGV inhibited PDGF mitogenic response (  Veracini 
et al., 2006  ), it did not affect the one induced by EGF (  Fig. 3 B  ). 
This indicated that, in NIH 3T3 cells, EGF does not require 
  caveolae and/or cholesterol-enriched membrane domains for 
mitogenesis. Interestingly, PAG-N also had no effect on EGF 
cellular response, whereas it still inhibited the one elicited by 
PDGF (  Fig. 3 C  ). We concluded that PAG-N function is tightly 
linked to the signaling processes dependent on membrane do-
mains such as caveolae. 
  PAG-N displaces PDGFR from caveolae, 
leading to the prevention of Src mitogenic 
signaling 
  We next addressed the molecular mechanism by which PAG-N 
inhibits SFK mitogenic function in greater detail. Because PAG-N 
may affect signaling upstream of SFK, we hypothesized that 
it could inhibit SFK-PDGFR coupling in caveolae. This idea 
was fi  rst evaluated in CEF of HEK 293 cells expressing human 
PDGFR     , with or without PAG-N. Surprisingly, PAG-N re-
duced PDGFR level in CEF by 50%, whereas SFK concentra-
tion remained unchanged (  Fig. 4 A  , left). 
[ID]FIG4 [/ID]  Moreover, PAG-N 
did not affect the total level of the receptor (  Fig. 4 A  , right), 
thus excluding any protein degradation mechanism. The speci-
fi  city of this inhibition was also illustrated by the inability of 
PAG-N CC/AA to displace the receptor from CEF. We con-
fi  rmed these observations by electron microscopy using immuno-
gold labeling of PDGFR in caveolae of NIH 3T3 cells infected 
with mock or PAG-N retroviruses. Indeed, although 50% of 
  caveolae were positive for PDGFR immunolabeling in control 
cells,   <  10% were positive in PAG-N  –  expressing cells (  Fig. 4 B  ). 
In contrast, PAG-N did not affect the caveolar immunogold 
labeling of caveolin, thus confi  rming the specifi  city of this ef-
fect (  Fig. 4 C  ). We concluded that PAG-N specifi  cally excludes 
PDGFR from caveolae. 
  We then addressed the biological consequence of PDGFR 
caveolar depletion on Src mitogenic signaling. Although PDGFR 
association with SFK was observed in CEF from PDGF-stimulated 
control cells, complex formation was largely reduced in cells 
infected with PAG-N (  Fig. 5 A  ). 
[ID]FIG5 [/ID]  PAG-N also increased the 
the PAG-N mutant fused to the GFP, which comprises only the 
fi  rst 97 aa encompassing the extracellular/transmembrane do-
mains, and a short cytoplasmic sequence without any obvious 
binding motifs for signaling proteins. Remarkably, PAG-N was 
suffi  cient to mimic the antimitogenic effect of full length PAG. 
Moreover, coexpression of PAG-N with Myc or RacV12 restored 
the mitogenic response of these cells upon PDGF stimulation 
(  Fig. 2 B  , right). Conversely, expression of PAG-C [98  –  433] 
fused to GFP, which could still associate with Csk, did not affect 
mitogenesis (  Fig. 2, B   [right]   and C   [middle and right]). We ob-
tained similar data when PAG-N was transduced by retroviral in-
fection, which induced moderate protein expression and, thus, 
excluded a nonspecifi  c inhibitory effect caused by high protein 
expression (  Fig. 3 C  ). 
[ID]FIG3[/ID]  In conclusion, PAG-N is suffi  cient to in-
hibit Src mitogenic signaling. 
  PAG-N does not have an impact on growth 
factor signaling outside caveolae 
  We next investigated how membrane partitioning of PAG-N 
  affects its activity. To this aim we used caveolae-enriched frac-
tions (CEF) purifi  ed from HEK 293 cells expressing PAG-N. 
  Figure 3.       PAG-N does not regulate growth factor signaling outside caveolae.   
(A) PAG-N does not affect PDGF-induced dorsal rufﬂ  es  ’   formation. (A, left) 
An example of circular dorsal rufﬂ  e formation assessed by actin staining 
in NIH 3T3 cells infected with the indicated retroviruses, stimulated or not 
with PDGF for 10 min. (A, right) Statistical analysis of dorsal rufﬂ  e forma-
tion in cells infected with the shown retroviruses, treated, or not, with 5   μ  M 
SU6656 for 30 min and stimulated with PDGF for 10 min. (B) EGF-induced 
mitogenic response is not regulated by caveolae in NIH 3T3 cells. Quies-
cent cells transfected with Cav3-DGV were stimulated with 25 ng/ml PDGF 
or 100 ng/ml EGF in the presence of BrdU. (C) PAG-N does not affect 
EGF-induced DNA synthesis. The percentage of transfected (or infected) 
cells that incorporated BrdU or that formed dorsal rufﬂ  es was calculated 
as described in Material and methods. Results are expressed as the mean   ±   
SD of three to ﬁ  ve independent experiments. **, P   <   0.01 (using Stu-
dent  ’  s   t   test).     607 SRC REGULATION BY PAG/CBP   • Veracini et al. 
PAG-N  –  expressing cells. This was confi  rmed by electron micros-
copy, which showed that 70% of mature caveolae were con-
nected to the surface of cells expressing PAG-N as compared 
with 25% in mock-infected cells (Fig. S2, available at http://
www.jcb.org/cgi/content/full/jcb.200705102/DC1). This fi  nding 
suggested that PAG-N modulates caveolae properties and/or 
endocytosis. In addition to caveolin, lipid constituents, such as 
cholesterol and ganglioside GM1, also play important roles in 
caveolae functions (  Sharma et al., 2004  ). Remarkably, we ob-
served a large accumulation of GM1 at the surface of cells ex-
pressing PAG-N (  Fig. 6 A  ). 
[ID]FIG6[/ID]  This accumulation was dependent 
on the membrane domain localization of the adaptor, as the 
  mutant PAG-N CC/AA did not modify GM1 membrane level. 
A moderate but signifi  cant accumulation of cholesterol was also 
association of SFK with caveolin, which is thought to partici-
pate in its catalytic inactivation (  Li et al., 1996  ). Reduction of 
SFK  –  PDGFR complex formation was also suggested by a de-
crease of PDGF-induced SFK activation as well as 
phosphorylation of the Src mitogenic substrates Stat3, Tyr705, 
Shc, Tyr239, and Tyr240 (  Bromann et al., 2004  ) in cells ex-
pressing PAG-N (  Fig. 5, B and C  ). Conversely, activation of 
ERK1 and 2 upon PDGF stimulation was not modifi  ed ( Fig. 5 D ), 
indicating that PAG-N does not inhibit all signaling pathways 
emanated from the activated receptor but only the caveolae-
regulated signaling. 
  PAG-N displaces PDGFR from caveolae 
via GM1 
  We then investigated how PAG-N depletes PDGFR from caveo-
lae. Because PAG-N does not interact physically with PDGFR 
(unpublished data), we reasoned that it may affect caveolae 
properties necessary for PDGFR localization. Indeed, we ob-
served a drastic redistribution of caveolin at the periphery of 
  Figure 4.       PAG-N excludes PDGFR from caveolae.   (A) PAG-N reduces the 
level of PDGFR in CEF of HEK 293 cells expressing PDGFR. Cells were 
transfected with the indicated constructs and lysed with 1% Triton X-100 
lysis buffer followed by sucrose gradient fractionation. Levels of PDGFR, 
caveolin, and SFK in CEF are shown. Levels of PDGFR and PAG mutants in 
a whole cell lysate (WCL) are also shown. Molecular masses are indicated 
in kilodaltons. (B) An example (arrows indicated PDGFR-labeled caveolae; 
left) and statistical analysis (mean   ±   SD; right) of PDGFR immunogold label-
ing in caveolae of NIH 3T3 cells infected with the indicated constructs are 
shown. (C) PAG-N does not affect caveolin localization in caveolae. An 
example (arrows indicate caveolin-labeled caveolae; left) and statistical 
analysis (mean   ±   SD; right) of caveolin immunogold labeling in caveolae 
of NIH 3T3 cells infected as indicated are shown. **, P   <   0.01 (using 
Student  ’  s   t   test).     
  Figure 5.       PAG-N inhibits SFK mitogenic signaling.   (A) PDGFR  –  SFK com-
plex formation is reduced in CEF of NIH 3T3 cells infected with PAG-N. 
Quiescent cells infected with the indicated retroviruses were stimulated with 
PDGF for 10 min. SFK association with caveolin and active PDGFR in CEF 
were evaluated by Western blotting of immunoprecipitated kinases with the 
indicated antibodies. Level of immunoprecipitated SFK is also shown. (B) Src 
mitogenic signaling is affected by PAG-N. SFK activity was measured by 
Western blotting with anti-pY416 antibody (left) or by in vitro kinase assay 
using denatured enolase (right) from immunoprecipitated kinases of the 
indicated cells stimulated or not with PDGF. Quantiﬁ  cation (mean   ±   SD) of 
SFK activity was expressed as the ratio between active SFK and total SFK 
levels. (C) PAG-N inhibits phosphorylation of SFK mitogenic substrates. 
Levels of Stat3 and Shc phosphorylated on Tyr705 (left) or on Tyr239 and 
Tyr240 (right) are shown for cells infected with the indicated retroviruses. 
(D) PAG-N does not affect PDGF-induced Erk1-2 activation. Lysates of the 
indicated cells stimulated, or not, with PDGF for the indicated times were 
subjected to Western blotting with anti  –  phospho-Erk and anti-Erk  –  speciﬁ  c 
antibodies. Molecular masses are indicated in kilodaltons. *, P   <   0.05 
(using Student  ’  s   t   test).     JCB • VOLUME 182 • NUMBER 3 • 2008  608
observed at the surface of cells stably expressing PAG-N in 
comparison to mock-infected cells (unpublished data), confi  rm-
ing that PAG-N alters caveolae constituents. We then analyzed 
the effect of such modifi  cations in membrane lipid constituents 
on PDGFR membrane partitioning. Previous reports suggested 
  Figure 6.       PAG-N displaces PDGFR from caveolae and inhibits Src mito-
genic signaling via GM1.   (A) PAG-N increases GM1 content at the cell 
surface. Representative example of quiescent NIH 3T3 cells transfected 
with the indicated constructs and stained for GM1 at the cell surface with 
CTxB  –  Alexa 594. Arrows indicate the GM1 staining of transfected cells. 
(B) Exogenous GM1 reduces PDGFR level in CEF. HEK 293 cells express-
ing PDGFR were treated at 4  °  C with 10   μ  M GM1 for 30 min and then frac-
tionated through a sucrose gradient. Levels of PDGFR and caveolin in CEF 
are shown as well as the level of PDGFR in whole cell lysates. Molecular 
masses are indicated in kilodaltons. (C) PAG-N depletes caveolar PDGFR 
via GM1. Representative example (left) and statistical analysis (right) of 
NIH 3T3 cells treated with GM1 or ethanol (vehicle) and then subjected to 
PDGFR immunogold labeling. Arrows highlight PDGFR-positive caveolae. 
(D) GM1 regulates PDGF-induced Src mitogenic signaling. Quiescent NIH 
3T3 cells transfected with the indicated constructs were incubated, or not, 
with 10   μ  M GM1 at 4  °  C for 30 min and stimulated with PDGF at 37  °  C 
for 18 h in the presence of BrdU. Cells were then ﬁ  xed and processed for 
immunoﬂ  uorescence. The percentage of transfected cells that incorporated 
BrdU was calculated as described in Material and methods. Results 
are expressed as the mean   ±   SD of three to ﬁ  ve independent experiments. 
**, P   <   0.01 (using Student  ’  s   t   test).     
that PDGF localization could be regulated by GM1 (  Mitsuda et al., 
2002  ). Therefore, we hypothesized that exclusion of PDGFR 
from caveolae by PAG-N was mediated by GM1. Indeed, exog-
enous GM1 reduced PDGFR accumulation in CEF from HEK 
293 cells expressing the human receptor (  Fig. 6 B  ). This fi  nding 
was further confi  rmed by electron microscopy on NIH 3T3 
cells, where immunogold labeling of PDGFR in caveolae was 
reduced by 80% upon addition of exogenous GM1 (  Fig. 6 C  ). 
We then asked whether GM1 could also influence PDGF-
  induced mitogenesis. Exogenous GM1 reduced PDGF mitogenic 
response by 70% (  Fig. 6 D  ). This inhibition was reversed by ex-
pression of Myc or RacV12, two elements of the Src pathway 
(  Bromann et al., 2004  ;   Boureux et al., 2005  ). In contrast, it was 
not modifi  ed by expression of the constitutively active RasL61 
mutant or the transcription factor Fos, demonstrating that GM1 
inhibitory effect was independent of Ras. We concluded that an 
excess of GM1 at the plasma membrane delocalizes PDGFR from 
caveolae and inhibits PDGF mitogenic response via inhibition 
of an Src-dependent signaling pathway. 
  The ganglioside-speciﬁ  c sialidase 
Neu-3 mediates PAG-N  –  induced GM1 
antimitogenic effects 
  We next sought to try to understand how PAG-N induces cell 
surface GM1. The effect of PAG-N CC/AA suggested a role 
for membrane domain localization in this molecular process. 
Furthermore, we found that caveolin-1 knockdown also reduced 
the capacity of PAG-N to impact on GM1 (  Fig. 7, A and B  ), 
suggesting that caveolin or caveolae integrity might be also 
required. 
[ID]FIG7 [/ID]  The ganglioside-specifi  c sialidase Neu-3 allows the 
conversion of di- and trisialidated gangliosides to monosialidated 
glycolipids such as GM1. Interestingly, this enzyme is localized 
at the external leafl  et of the plasma membrane and interacts with 
caveolin (  Wang et al., 2002  ;   Papini et al., 2004  ). We thus inves-
tigated whether Neu-3 was involved in PAG-N  –  induced GM1 
effects. Neu-3 knockdown strongly reduced GM1 cell surface 
accumulation elicited by PAG-N (  Fig. 7, A  –  C  ). We confi  rmed 
this result using 2-deoxy-2,3-didehydro-  N -acetylneuraminic 
acid (DANA), which specifi  cally inhibits cell surface  –  localized 
Neu-3 (  Da Silva et al., 2005  ). DANA treatment largely reversed 
both PAG-N  –  induced GM1 cell surface accumulation and PDGFR 
displacement from caveolae, confi  rming Neu-3 knockdown ex-
periments (  Fig. 7, A, B, and D  ). We then addressed the bio-
logical impact of Neu-3 activity on PAG-N antimitogenic effect. 
Neu-3 inhibition, either with DANA (  Fig. 7 E  , left) or through 
Neu-3 siRNA transduction (  Fig. 7 E  , right), largely reversed 
PAG-N mitogenic inhibition. Collectively, these data point to GM1 
as a mediator of PAG-N antimitogenic function. Moreover, these 
observations stress that Neu-3 controls PAG-N  –  induced GM1 
antimitogenic effects. 
  PAG antimitogenic function is also 
mediated by a Neu3  –  GM1 pathway 
 We next asked whether full-length PAG could also inhibit PDGF 
mitogenic response through a similar mechanism. First, we found 
a similar GM1 accumulation at the cell surface of cells express-
ing PAG, which was abolished by the Neu-3 cell surface inhibitor 609 SRC REGULATION BY PAG/CBP   • Veracini et al. 
  Endogenous PAG regulates PDGF 
mitogenic activity via a GM1-dependent 
mechanism 
  Finally, we asked whether endogenous PAG had a similar role. 
To this end, mouse NIH 3T3 cells were stably transfected with 
a vector expressing a small hairpin RNA that reduced PAG 
level in CEF by 80%, as compared with mock-transfected cells 
( Fig.  9 A ). 
[ID]FIG9[/ID]  We observed that GM1 accumulation at the cell sur-
face was significantly reduced in PAG knocked-down cells 
(  Fig. 9 B  ). Remarkably, PDGFR caveolar distribution was sig-
nifi  cantly increased in cells with reduced PAG, as revealed 
by the appearance of multi-labeled PDGFR beads in caveolae, 
whereas caveolin was not (  Fig. 9 C  ). In accordance with our 
hypothesis, exogenous GM1 largely restored PDGFR mono-
labeling in caveolae. We then addressed the effect of endogenous 
PAG on mitogenesis. PAG down-regulation induced an increase 
DANA (  Fig. 8 A  ). 
[ID]FIG8[/ID]  PAG also decreased PDGFR localization in 
caveolae, which was fully restored by lowering GM1 cell sur-
face level via Neu-3 inhibition with DANA (  Fig. 8 B  ). Most im-
portantly, DANA restored PDGF mitogenic response in cells 
expressing PAG (  Fig. 8 C  ). Thus, we concluded that PAG mito-
genic inhibition is ensured by its N terminus and implicates a 
Neu-3 – GM1  mechanism. 
  Figure 7.       The ganglioside sialidase Neu-3 mediates PAG-N  –  induced 
GM1 antimitogenic effects.   (A and B) PAG-N  –  induced GM1 cell surface 
accumulation requires caveolin and Neu-3 activity. An example (A) of cell 
surface GM1 level in PAG-N  –  expressing cells with knocked-down caveolin-1 
or Neu-3 is shown. PAG-N  –  expressing cells were transfected with the in-
dicated siRNA or treated with DANA, as indicated, and were stained 
with CTxB  –  Alexa 594. (B) Statistical analysis of the percentage of cells 
exhibiting speciﬁ  c staining (GM1-positive cells) is shown. (C) Knockdown 
of Neu-3 mRNA levels. Results are shown as the mean   ±   SD of three inde-
pendent experiments. (D) PDGFR immunogold labeling in PAG-N  –  expressing 
cells that were treated with 10   μ  M DANA. A representative example (left) 
and the statistical analysis (right) are shown. Arrows highlight PDGFR-
positive caveolae. (E) PAG-N mitogenic inhibition is reversed by Neu-3 in-
activation. NIH 3T3 cells, infected, or not, with the indicated retroviruses, 
were transfected with the indicated siRNAs (right), serum starved for 30 h 
with or without 10   μ  M DANA (left), and then stimulated or not with PDGF 
in the presence of BrdU. Cells were then ﬁ  xed and processed for immuno-
ﬂ  uorescence. The percentage of transfected cells that incorporated BrdU 
was calculated as described in Material and methods. Results are ex-
pressed as the mean   ±   SD of three to ﬁ  ve independent experiments. *, P   <   
0.05 (using Student  ’  s   t   test).     
  Figure 8.       PAG antimitogenic function is also mediated by a Neu3  –  GM1 
pathway.   (A) PAG induces cell surface GM1 accumulation mediated by 
Neu-3. A representative example of cell surface GM1 expression in NIH 
3T3 cells transfected with a full-length PAG construct (GFP) and treated or not 
with DANA as indicated. (B) PAG displaces PDGFR from caveolae. Shown 
are a representative example (left) and the statistical analysis (right) of 
PDGFR staining by immunogold with the anti-PRC antibody in caveolae 
of cells infected with a PAG-expressing retrovirus and treated, or not, with 
DANA. Arrows highlight PDGFR-positive caveolae. (C) PAG mitogenic in-
hibition requires Neu-3 activity. (C, left) NIH 3T3 cells infected with the 
indicated retroviruses were treated, or not, with 10   μ  M DANA and then 
stimulated, or not, with PDGF in the presence of BrdU. Cells were then ﬁ  xed 
and processed for immunoﬂ  uorescence. The percentage of transfected cells 
that incorporated BrdU was calculated as described in Material and meth-
ods. Results are expressed as the mean   ±   SD of three independent experi-
ments. (C, right) The level of expressed PAG. Molecular mass is indicated 
in kilodaltons.     JCB • VOLUME 182 • NUMBER 3 • 2008  610
PAG. We also found that increased DNA synthesis after PAG 
down-regulation was inhibited by AG-1296, a PDGFR inhibitor 
(  Kovalenko et al., 1997  ), but not by Iressa, a specifi  c inhibitor 
of EGF receptors (  Fig. 9 F  ;   Herbst et al., 2004  ). SFK and caveo-
lae were also implicated in this cellular response, as revealed 
by the inhibitory effect of the Src inhibitor SU6656 and the 
Cav3-DGV mutant, respectively. Accordingly, basal PDGFR 
and ERK activities were enhanced in these cells (  Fig. 9 G  ). 
Hence, an increased PDGFR signaling mediated by its mem-
brane redistribution may be responsible for the promotion of 
DNA synthesis in cells with reduced PAG. Finally, we also 
wished to confi  rm the Csk-independent nature of endogenous 
PAG activity. A 10-min PDGF stimulation induced Csk mem-
brane recruitment in 50% of cells, as revealed by Csk immuno-
staining at the plasma membrane (Fig. S3, A and B, available at 
in BrdU incorporation both in the presence and absence of 
growth factors (  Fig. 9 D  ), indicating that endogenous PAG 
negatively regulates mitogenesis. Interestingly, increase in BrdU 
incorporation was abrogated by exogenous GM1, which is in 
agreement with the hypothesis of a PAG  –  GM1 signaling path-
way regulating mitogenesis. We then analyzed the molecular 
determinants involved in endogenous PAG biological activity 
by introducing human PAG mutants that were not targeted by 
the mouse shRNA sequence (  Fig. 9 E  ). Human PAG restored 
DNA synthesis to the level observed in control cells, indicating 
that the biological effect was not caused by a side target of the 
shRNA. Similar results were obtained with PAG Y317F and 
PAG-N, which do not bind to Csk, unlike PAG-C. These data 
are consistent with the idea that the N-terminal sequence is re-
sponsible for the mitogenic inhibitory activity of endogenous 
  Figure 9.       Endogenous PAG regulates PDGF 
mitogenic activity by a GM1-dependent mech-
anism.   (A)   PAG   silencing in NIH 3T3 cells. 
Levels of PAG and caveolin in CEF from cells 
expressing the indicated shRNAs. (B) PAG 
knockdown reduces GM1 cell surface level. 
A representative example of cell surface GM1 
level in NIH 3T3 cells expressing the indicated 
shRNAs is shown. (C, left) PAG knockdown in-
creases PDGFR caveolar distribution, but this 
effect is reversed by GM1 addition. PDGFR 
and caveolin immunogold labeling in cells ex-
pressing PAG shRNA and treated, or not, with 
GM1. Arrows highlight caveolin or PDGFR-
labeled caveolae. (C, right) statistical analysis 
of the percentage of caveolae that were multi-
labeled with the anti-PDGFR antibody (    PRC) in 
the indicated cells treated, or not, with GM1. 
(D) PAG knockdown increases DNA synthesis 
that is dependent on GM1 and PAG-N. NIH 
3T3 cells infected with the indicated retro-
viruses were treated with 10   μ  M GM1 or vehicle 
during starvation and then stimulated, or not, 
with PDGF in the presence of BrdU. (E) PAG 
negative regulation of DNA synthesis induc-
tion requires PAG-N. NIH 3T3 cells, infected 
with the indicated retrovirus, were transfected 
with different human PAG coding vectors. (F) PAG 
negative regulation of DNA synthesis requires 
PDGFR. NIH 3T3 cells, infected with the indi-
cated viruses, were transfected with Cav3-
DGV or treated with the indicated reagents 
and then incubated with BrdU in the absence 
of PDGF for 18 h. Cells were then ﬁ  xed and 
processed for immunoﬂ  uorescence. The per-
centage of transfected cells that incorporated 
BrdU was calculated as described in Mate-
rial and methods. Results are expressed as 
the mean   ±   SD of three to ﬁ  ve independent 
experiments. (G) PDGFR and Erk activation in 
cells expressing the indicated shRNAs. Levels 
of phosphorylated and total PDGFR and Erk 
were assessed by Western blotting with the 
indicated antibodies. Molecular masses are 
indicated in kilodaltons.*, P   <   0.05; **, P   <   
0.01 (using Student  ’  s   t   test).     611 SRC REGULATION BY PAG/CBP   • Veracini et al. 
and GM1 accumulation through separate mechanisms. A second 
hypothesis implies that PAG has an impact on GM1 biosynthesis. 
This notion is supported by the important role of the membrane 
domain  –  localized sialidase Neu-3 (  Wang et al., 2002  ;   Papini 
et al., 2004  ) on PAG activity. Thus, PAG may have an impact on 
Neu-3 by modulating its expression, localization, enzymatic 
  activity, and/or substrate availability. We also demonstrated 
that PAG functions require palmitoylation of the protein for its 
localization in membrane domains (  Uittenbogaard and Smart, 
2000  ). Surprisingly, these properties were not observed in any 
other member of the TRAP family we tested (i.e., LAT, SIT, 
TRIM, and NTAL; unpublished data), including the ones that 
also harbor palmitoylation sites (LAT and NTAL). Therefore, 
additional mechanisms must be required for full PAG activity. 
Accordingly, a detailed mutagenesis analysis identifi  ed Phe 25, 
32, and 35 as important determinants of PAG-N functions, 
which defi  ne a consensus sequence for binding to caveolin-1 
(X   XXXX  XX  ,  where      corresponds to Phe, Tyr, or Trp, 
and X to any other amino acid;   Couet et al., 1997  ;   Jiang et al., 
2006  ). However, the endogenous proteins were found to inter-
act weakly in cells (unpublished data), suggesting that this se-
quence might have additional roles. 
  Moreover, the present fi  ndings raise the issue of the nature 
of the membrane-anchored Csk binders involved in the regula-
tion of Src mitogenic signaling.   Zhao et al. (2006)   clearly impli-
cated the adaptor protein Dok-1. Using Src phosphorylation on 
Tyr450, Dok-1 recruits Csk to the cell periphery for regulation 
of Src-induced   c-myc   expression and cell cycle progression. 
However, they did not investigate whether Dok-1 regulates sig-
naling in caveolae. Additional Csk-binding proteins could be 
involved in the regulation of SFK mitogenic signaling. One ob-
vious candidate may be caveolin-1 itself, when it is phosphory-
lated on Tyr14 by SFK (  Lee et al., 2000  ). 
  Finally, our study raises important questions about PAG 
signaling specifi  city and PAG regulation. Our data show that 
PAG action is restricted to specifi  c membrane domains. There-
fore, we could also expect that PAG impact on receptor signaling 
http://www.jcb.org/cgi/content/full/jcb.200705102/DC1).   PAG  
silencing had no effect on Csk relocalization and mitogenic ac-
tivity (Fig. S3 C), as expected. Nevertheless, the specifi  c SFK 
inhibitor SU6656 strongly reduced Csk relocalization, confi  rm-
ing the existence of a distinct SFK substrate for Csk membrane 
translocation and activity. 
  Discussion 
  PAG was originally identifi  ed as a Csk-binding protein and 
a phosphoprotein associated with glycosphingolipid-enriched 
microdomains (i.e., membrane rafts). So far, PAG functions 
were mostly related to Csk activation (  Horejsi et al., 2004  ). 
Recently, additional PAG-interacting proteins with signaling 
functions have been reported, including the E3 ligase SOCS1, 
which is important for SFK degradation (  Ingley et al., 2006  ), 
the negative Ras regulator RasGAP (  Smida et al., 2007  ), and 
SFK as well ( Oneyama et al., 2008 ;  Solheim et al., 2008 ;  Tauzin 
et al., 2008  ). In this paper, we have uncovered a novel property 
of this transmembrane protein, unrelated to its association with 
Csk or any other signaling protein yet implicating SFK regula-
tion. By controlling GM1 levels at the plasma membrane, PAG 
regulates PDGFR partitioning in caveolae and its association 
with SFK for mitogenic signaling. Recent data have shown 
that PAG can sequester and affect signaling of oncogenic SFK 
in membrane domains and this implicates a phosphotyrosine-
dependent mechanism (  Oneyama et al., 2008  ). This may not 
occur in PDGF-stimulated fibroblasts, probably because of 
the ineffi  ciency of endogenous SFK to phosphorylate PAG in 
these conditions. 
  How GM1 regulates PDGFR levels in caveolae is not 
clearly established, but the simplest model would implicate a 
competition mechanism. In addition, one might speculate that 
there is repulsion between the GM1 carbohydrate moiety and 
an epitope in the extracellular domain of PDGFR, as was re-
cently found for the ganglioside GM3 and the insulin receptor 
(  Kabayama et al., 2007  ). Thus, the balance between the two 
constituents would regulate PDGFR concentration in these mem-
brane domains. Additionally, GM1 may also regulate PDGFR 
catalytic activity, as suggested by   Mistuda et al. (2002)  , and 
by the increased PDGFR activity observed in PAG-depleted 
cells with reduced GM1 level. Therefore, by regulating GM1 
level at the plasma membrane, PAG may have an impact on 
PDGFR mitogenic signaling via both receptor membrane par-
titioning and catalytic activity (  Fig. 10  ). 
[ID]FIG10[/ID]  
  One important issue raised by these observations is to under-
stand how PAG regulates GM1 accumulation. A fi  rst hypothesis 
implies that, by associating with GM1, it allows lipid delivery 
to the cell surface, as was recently described for syntaxin-6, a 
t-SNARE (target membrane – soluble N-ethylmaleimide attach-
ment protein receptor) involved in membrane fusion events along 
the secretory pathway (  Choudhury et al., 2006  ). Indeed, syn-
taxin-6 controls the level of GM1 in caveolae and we observed 
that its overexpression also inhibits PDGF-induced Src mito-
genic signaling (unpublished data). However, syntaxin-6 func-
tions were not affected by PAG down-regulation (unpublished 
data), suggesting that these two proteins regulate mitogenesis 
  Figure 10.       A model for how PAG regulates PDGFR-induced DNA synthesis.   
Under normal conditions, PDGF-induced receptor activation triggers its as-
sociation with SFK in caveolae, leading to Src mitogenic signaling, which 
is required for induction of DNA synthesis. An increase in PAG level in-
duces Neu-3 sialidase activity that leads to GM1 accumulation and PDGFR 
exclusion from caveolae. This, in turn, prevents Src mitogenic signaling 
and induction of DNA synthesis. Conversely, a reduction of PAG level low-
ers Neu-3 sialidase activity and GM1 cell surface accumulation, allowing 
an increase in PDGFR caveolar localization. This induces PDGFR activation 
and Src mitogenic signaling even in the absence of PDGF.     JCB • VOLUME 182 • NUMBER 3 • 2008  612
tions were performed with Lipofectamine Plus Reagent (Invitrogen) or jetPEI 
(Polyplus-transfection) according to the manufacturer  ’  s instructions. For bio-
chemical analysis, cells were transfected 40 h before lysis. For DNA syn-
thesis experiments, cells seeded onto glass coverslips were serum starved 
in medium containing 0.25% serum supplemented with insulin-transferrin-
selenium buffer (Invitrogen) for 30 h and then stimulated, or not, with the 
indicated mitogens. 
  BrdU incorporation and immunoﬂ  uorescence 
  DNA synthesis in quiescent ﬁ  broblasts seeded onto glass coverslips was 
monitored by adding 0.1 mM BrdU to the medium for 18 h. For drug treat-
ments, cells were incubated with the indicated drug (or vehicle) 1 h before 
stimulation, except for DANA which was added during serum starvation. 
For GM1 experiments, cells were treated with 10   μ  M GM1 for 30 min at 
4  °  C before stimulation. Cells were then ﬁ   xed and analyzed for BrdU 
incorporation and dorsal rufﬂ  e formation as in   Veracini et al. (2006)  . The 
percentage of transfected cells that incorporated BrdU was calculated by 
the following formula: % of BrdU-positive cells = [number of BrdU-positive 
transfected cells]/[number of transfected cells]   ×   100. The percentage of 
transfected cells that formed dorsal rufﬂ  es was calculated by the following 
formula: % of cells with dorsal rufﬂ  e = [number of rufﬂ  es-positive trans-
fected cells]/[number of transfected cells]   ×   100. For each coverslip 
    150  –  200 cells were analyzed. Cell surface GM1 and cholesterol levels 
were visualized on PFA-ﬁ  xed cells by incubation with 0.1   μ  g/ml CTxB  – 
Alexa 594 and 5   μ  g/ml ﬁ  lipin, respectively, in PBS  –  10% FCS. Fluorescent 
labeling was observed with a motorized microscope (DMRA; Leica) using 
a 40 or 63  ×   plasmapochromatic oil immersion objective (1.32 NA) in 
Mowiol. Acquisition was performed with a camera (coolSNAP HQ; Photo-
metrics) driven by the MetaMorph 6.2r4 acquisition software (MDS Ana-
lytical Technologies). 
  Transmission electron microscopy (TEM) 
  TEM was performed on thin sections of epon-embedded cells. Monolayers 
of cells grown in 100-mm dishes were ﬁ  xed with 2.5% glutaraldehyde in 
0.1 M Na cacodylate buffer, pH 7.4, postﬁ  xed in 1% OsO4 in the same 
buffer, dehydrated through graded series of ethanol, removed from the 
dish by propylene oxide, and pelleted, followed by epon embedding. Thin 
sections were stained with uranyl acetate and lead citrate and observed 
with a transmission electron microscope (1200 EX; Jeol). TEM was per-
formed on ultrathin cryosections and after immunogold labeling. Cells 
were ﬁ  xed with 4% PFA in 0.1 M phosphate buffer, pH 7.2, for 48 h at 
4  °  C. After ﬁ  xation, cells were scraped off, let to sediment for 30 min at RT, 
microfuged for 1 min, and then embedded in 5% gelatin in PBS for 30 min 
at 37  °  C. After cooling on ice and trimming, cell pellets were infused over-
night in 2.3 M sucrose, mounted on aluminum stubs, and frozen in liquid 
nitrogen. Ultrathin sections were cut with microtomes (UCT and EMFCS; 
Leica) and a Diamond knife, collected with 2.3 M sucrose, and mounted 
on Parlodion-coated copper or nickel grids. Sections were incubated with 
rabbit polyclonal anti-PDGFR and -caveolin antibodies diluted 1:200 in 
PBS  –  10% FCS for 30 min, and then with protein A gold conjugates diluted 
1:70 in PBS  –  10% FCS for 30 min to 1 h. Sections were then embedded in 
methyl cellulose uranyl acetate before drying and observation with a trans-
mission electron microscope (EM10 CR; Carl Zeiss, Inc.). 
  Biochemistry 
  Cell lysis, immunoprecipitation, Western blotting, and in vitro kinase assays 
were performed as in   Veracini et al. (2006)   and results were quantiﬁ  ed us-
ing the ImageQuant TL software (Molecular Dynamics). For fractionation 
experiments, 10 
8   cells were incubated with vehicle or 25 ng/ml PDGF for 
10 min at 37  °  C, rinsed with PBS, scraped in 1 mM of ice-cold PBS-containing 
vanadate, and pelleted. Pellets were then suspended in ice-cold 2  ×   lysis 
buffer containing 1% Triton X-100, 10 mM Tris-HCl, pH 7.5, 150 mM 
NaCl, 5 mM EDTA, 75 U/ml aprotinin, and 1 mM vanadate for 20 min. 
Cell suspensions were homogenized in a tight-ﬁ  tting Dounce homogenizer 
with 10 strokes and centrifuged for 5 min at 1,300   g   to remove nuclei and 
large cellular debris. Supernatants were fractionated through a 5  –  42.5% 
wt/vol sucrose gradient in 4-ml tubes. Nine fractions were collected from 
the top to the bottom of the gradient. In some experiments, fractions two 
through four were pooled and diluted ﬁ  vefold in 25 mM MOPS, pH 6.5, 
and 150 mM NaCl containing 1% Triton X-100 and centrifuged at 50,000   g   
at 4  °  C for 30 min. Pellets were then suspended in dissociation buffer 
containing 10 mM Tris, pH 7.5, 150 mM NaCl, 5 mM EDTA, 0.5 mM 
EGTA, 1 mM vanadate, 50 mM NaF, 75 U/ml aprotinin, 1% NP 40, and 
60 mM octylglucoside and incubated for 1 h on ice before SFK immuno-
precipitation with the anti-cst1 antibody. 
regulated by these membrane domains. For instance, NGF re-
ceptors have been reported to require GM1 for neurite out-
growth ( Mutoh et al., 1995 ), and PAG, which is highly expressed 
in the brain (  Kawabuchi et al., 2000  ), may also contribute to the 
ability of NGF to induce neurites. Additional work is certainly 
needed to defi  ne the regulation of this novel PAG function. Reg-
ulation of protein expression could be part of the mechanism, 
as suggested by our gene silencing experiments. Another level 
of regulation may implicate deacylation on Cys39 and Cys42 
(  Greaves and Chamberlain, 2007  ). By removing palmitoyl resi-
dues, PAG will be excluded from membrane domains and will 
not have an impact on GM1 at the cell surface. Although not 
predicted, phosphorylation at the N terminus could also infl  u-
ence PAG antimitogenic function. Clearly, further investiga-
tions are required to unravel the molecular mechanism by which 
this GM1-mediated PAG function is regulated. 
  Materials and methods 
  DNA constructs, antibodies, and reagents 
  Constructs expressing PAG and PAGY317F have been described in 
  Brdicka et al., (2000)  . PAG-N and PAG-C correspond to human PAG 
[1  –  97] and PAG [98  –  433] sequences that have been subcloned in frame 
into pEGFP-N2 and pEGFP-C2 vectors, respectively. PAG-N CC/AA (PAG-N 
C  39  C  42  /A  39  A  42  ) and PAG-N 3F/3A (PAG-N F  25  F  32  F  35  /A  25  A  32  A  35  ) mutants 
were generated using PAG-N as template and the Quick Change Site Di-
rected mutagenesis kit (Stratagene) and subcloned into the pBabe retro-
viral vector. Constructs expressing Myc, Fos, E1B, and SrcY527F have been 
described in   Furstoss et al., (2002)   and   Franco et al. (2006)  , Rac V12 in 
  Boureux et al. (2005)  , Csk in   B  é  nistant et al. (2001)  , and Cav3 DGV and 
Cav1-GFP in   Veracini et al. (2006)  . Construct encoding RasL61 was ob-
tained from P. Fort (Centre de Recherche en Biochimie Macromol  é  culare, 
Montpellier, France), PDGFR was obtained from A. Kazlauskas (Harvard 
Medical School, Boston, MA), and syntaxin6 was obtained from S.A. 
Tooze (London Research Institute, London, United Kingdom). The shRNA 
speciﬁ   c for mouse PAG (GTCCAAGTCCACTTCTGCC) was cloned into 
pSUPER vector. A pSuper construct expressing a siRNA against the un-
related human protein interferon receptor 1 was used as a control (gift 
from A. Blangy and G. Uz  é  , Centre de Recherche en Biochimie Macro-
mol  é  culare, Montpellier, France). siRNAs speciﬁ   c for mouse Caveolin-1 
(AAGCAAGTGTATGACGCGCAC), mouse Neu-3 (AAGGATTAACCTAG-
GCATCTA), and corresponding scramble siRNAs were obtained from QIA-
GEN. Neu-3 mRNA levels were measured by real-time quantitative PCR 
(  Boureux et al., 2005  ) using the following primers: forward, 5    -GCCC-
GTCTCTGCTTCCTTT-3    ; and reverse, 5    -CTTCCCGAGTGTAGCTGGATG-3    . 
Anti-SFK (cst1), -PDGFR     (PRC), and -myc epitope (9E10) antibodies were 
described in   Boureux et al. (2005)   and   Franco et al. (2006)  . The anti-
pY  416  Src antibody was obtained from Invitrogen, anti  –  pan-caveolin from 
BD Biosciences, anti-ERKs (SC-94) and -Csk from Santa Cruz Biotechnol-
ogy, Inc., anti-pY  705  Stat3 from Cell Signaling Technology, anti-Stat3 from 
Millipore, anti  –  phospho-ERKs from New England Biolabs, Inc., and anti-
BrdU from Becton Dickinson. Anti-Flag antibody and ﬁ  lipin were obtained 
from Sigma-Aldrich, anti-4G10 and anti-tubulin were obtained from 
P. Mangeat and N. Morin, respectively (Centre de Recherche en Biochimie 
Macromol  é  culare, Montpellier, France). Antibodies coupled to Fluorescein 
isothiocyanate and Texas Red isothiocyanate were obtained from Sigma-
Aldrich, Rhodamine phalloidin and cholera toxin subunit B (CTxB)  –  Alexa 
Fluor 594 were obtained from Invitrogen, BrdU from Boehringer Ingelheim, 
PDGF-BB from Abcys, and EGF and DANA from Sigma-Aldrich. SU6656 
and AG-1296 were obtained from EMD, GM1 from Avanti Polar Lipids, 
and Iressa was a gift of F. Cruzalgui (Servier Laboratories, Paris, France). 
Protein A gold conjugates were obtained from the Cell Microscopy Center 
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